Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Basal cell carcinoma	11/63	2.606188480044595E-4	0.08027060518537353	0	0	3.4920634920634916	28.818084849256323	FZD1;FZD5;GADD45B;GADD45A;SUFU;WNT7B;PTCH2;AXIN1;FZD9;DVL3;TP53
Small cell lung cancer	13/93	7.139572175123356E-4	0.10994941149689968	0	0	2.7956989247311825	20.253965100928117	CDKN2B;CHUK;GADD45B;LAMC3;ITGA3;GADD45A;PTEN;TRAF2;CCNE2;COL4A1;CKS2;CYCS;TP53
Renal cell carcinoma	10/69	0.002169258546810801	0.2227105441392422	0	0	2.898550724637681	17.77788363279479	FLCN;ARNT2;PAK1;PRCC;CUL2;RAPGEF1;PDGFB;SOS2;MET;PAK2
Human papillomavirus infection	28/330	0.004586869815654471	0.3531889758053943	0	0	1.696969696969697	9.137430815625448	PATJ;MAML1;LAMC3;TNC;PTEN;OASL;PPP2R1A;DVL3;HES4;FZD1;ATP6V0B;TBP;FZD5;CHUK;ITGA3;WNT7B;FZD9;AXIN1;PPP2R3A;CCNA2;CCNE2;COL4A1;COL6A1;GNAS;MDM2;TP53;SOS2;IFNAR1
p53 signaling pathway	9/72	0.009484293950526655	0.5842325073524419	0	0	2.5	11.645295292243906	CCNE2;GADD45B;GADD45A;CCNG2;PTEN;MDM2;CYCS;RCHY1;TP53
Steroid biosynthesis	4/19	0.01318872540853091	0.67702123763792	0	0	4.2105263157894735	18.224812421427043	SOAT1;SC5D;MSMO1;LIPA
Pathways in cancer	38/530	0.01668758986971434	0.734253954267431	0	0	1.4339622641509433	5.869336542665459	CALML5;LAMC3;CUL2;PDGFB;PTEN;TFG;SUFU;DVL3;IL6R;FZD1;STAT5A;ARNT2;CDKN2B;RALBP1;FZD5;CHUK;GADD45B;ITGA3;GADD45A;IFNGR2;WNT7B;PTCH2;FZD9;AXIN1;TRAF2;F2;ADCY9;CCNE2;COL4A1;KIT;CKS2;MDM2;GNAS;CYCS;SOS2;MET;TP53;IFNAR1
Hepatocellular carcinoma	15/168	0.021489063698149326	0.827328952378749	0	0	1.7857142857142856	6.857519890115907	FZD1;SMARCE1;FZD5;GADD45B;PHF10;GADD45A;WNT7B;FZD9;PTEN;AXIN1;ARID1A;DVL3;TP53;SOS2;MET
MAPK signaling pathway	23/295	0.023789968315902597	0.8141455823664444	0	0	1.5593220338983051	5.8295118365643335	HSPA8;JUND;GADD45B;CHUK;GADD45A;SRF;PDGFB;RRAS2;TRAF2;MAPK8IP1;NR4A1;PPM1A;PAK1;DUSP10;MAPKAPK3;KIT;TP53;PAK2;LAMTOR3;SOS2;MET;MAP2K5;MAP4K4
Human T-cell leukemia virus 1 infection	18/219	0.02681711281637571	0.8259670747443719	0	0	1.643835616438356	5.948572696963492	STAT5A;NRP1;CDKN2B;CRTC2;RANBP3;CDKN2C;CRTC3;TBP;CHUK;CRTC1;SRF;PTEN;CCNA2;ADCY9;XPO1;CCNE2;HLA-DOA;TP53
Melanogenesis	10/101	0.029580473987330068	0.8282532716452419	0	0	1.9801980198019802	6.971565936466181	FZD1;ADCY9;MC1R;CALML5;FZD5;WNT7B;KIT;FZD9;GNAS;DVL3
Glioma	8/75	0.03334767065271348	0.8559235467529794	0	0	2.1333333333333333	7.254970356385413	CALML5;GADD45B;GADD45A;PTEN;PDGFB;MDM2;SOS2;TP53
Gastric cancer	13/149	0.03622654138259297	0.8582903650645104	0	0	1.74496644295302	5.789734515258347	FZD1;CDKN2B;FZD5;GADD45B;GADD45A;WNT7B;FZD9;AXIN1;CCNE2;DVL3;TP53;SOS2;MET
Cholesterol metabolism	6/50	0.03757690396507332	0.826691887231613	0	0	2.4	7.875277616560796	STARD3;SOAT1;LRP1;APOC3;LIPA;PLTP
mTOR signaling pathway	13/152	0.04150085563953877	0.8521509024651961	0	0	1.7105263157894737	5.442965268919951	FZD1;FZD5;CHUK;WNT7B;FZD9;PTEN;FLCN;DDIT4;AKT1S1;DVL3;SOS2;LAMTOR3;TELO2
Cushing syndrome	13/155	0.04729311576218661	0.9103924784220923	0	0	1.6774193548387097	5.118461547976306	FZD1;CDKN2B;CDKN2C;FZD5;WNT7B;FZD9;AXIN1;NR4A1;ADCY9;CCNE2;GNAS;DVL3;PDE8A
Fanconi anemia pathway	6/54	0.05175964311269336	0.9377629458064445	0	0	2.222222222222222	6.580321164119916	RMI2;FANCM;UBE2T;RPA1;PALB2;TELO2
Cellular senescence	13/160	0.05814883760924165	0.9949912213136906	0	0	1.625	4.622717758327802	CDKN2B;CALML5;GADD45B;GADD45A;PTEN;RRAS2;HIPK3;ZFP36L1;PPP1CA;CCNA2;CCNE2;MDM2;TP53
Hippo signaling pathway	13/160	0.05814883760924165	0.9426232622971805	0	0	1.625	4.622717758327802	FZD1;PATJ;FZD5;WNT7B;FZD9;AXIN1;CSNK1D;YWHAZ;PPP1CA;PAK1;PPP2R1A;DVL3;AMH
Breast cancer	12/147	0.06498348347211058	1.0	0	0	1.6326530612244896	4.4630565580482475	FZD1;FZD5;GADD45B;GADD45A;WNT7B;KIT;FZD9;PTEN;AXIN1;DVL3;TP53;SOS2
Vasopressin-regulated water reabsorption	5/44	0.06726261217595207	0.9865183119139638	0	0	2.2727272727272725	6.134433491895637	ADCY9;DCTN4;ARHGDIG;GNAS;AQP3
Melanoma	7/72	0.06783286284097932	0.9496600797737105	0	0	1.9444444444444444	5.231933192105025	GADD45B;GADD45A;PTEN;PDGFB;MDM2;TP53;MET
Endometrial cancer	6/58	0.06880939588139882	0.9214475622378625	0	0	2.068965517241379	5.537410293773416	GADD45B;GADD45A;PTEN;AXIN1;SOS2;TP53
Basal transcription factors	5/45	0.07270586423397986	0.9330585910027415	0	0	2.222222222222222	5.825184964955028	TBP;CCNH;TAF10;TAF8;GTF2E2
Gap junction	8/88	0.0729501407916859	0.8987457345535702	0	0	1.8181818181818181	4.759961952800132	GUCY1A2;ADCY9;TUBB1;PDGFB;GNAS;CSNK1D;SOS2;MAP2K5
One carbon pool by folate	3/20	0.07538936106098607	0.893073969491681	0	0	2.9999999999999996	7.755267341732064	MTFMT;ATIC;MTHFD2L
PPAR signaling pathway	7/74	0.07622483813171252	0.869527783132128	0	0	1.8918918918918919	4.869858207482098	SLC27A1;CPT1A;ACSL1;APOC3;ACADM;PLTP;SLC27A5
Epstein-Barr virus infection	15/201	0.07967701068027053	0.8764471174829758	0	0	1.4925373134328357	3.7757823626454146	GADD45B;CHUK;GADD45A;ADRM1;TRAF2;SAP30;CCNA2;MAVS;CCNE2;OAS2;MDM2;CYCS;HLA-DOA;TP53;IFNAR1
Fructose and mannose metabolism	4/33	0.08064706826013496	0.8565274835903989	0	0	2.4242424242424243	6.103449276278521	TIGAR;PFKFB3;AKR1B10;FBP1
Chronic myeloid leukemia	7/76	0.08519720761440963	0.874691331507939	0	0	1.8421052631578945	4.536712195036593	STAT5A;CHUK;GADD45B;GADD45A;MDM2;SOS2;TP53
Cell cycle	10/124	0.09227027017297251	0.9167497810734043	0	0	1.6129032258064515	3.8436020795588095	CCNA2;CDKN2B;CDKN2C;CCNE2;GADD45B;CCNH;GADD45A;MDM2;TP53;YWHAZ
Synaptic vesicle cycle	7/78	0.09474562652597404	0.9119266553125002	0	0	1.7948717948717947	4.2297223484243345	ATP6V0B;RAB3A;STXBP1;CLTCL1;AP2S1;STX2;SLC6A4
Thyroid cancer	4/37	0.11170784333278796	1.0	0	0	2.1621621621621623	4.739174827095357	TFG;GADD45B;GADD45A;TP53
Focal adhesion	14/199	0.12516246013554705	1.0	0	0	1.4070351758793969	2.9240198856580637	LAMC3;ITGA3;PDGFB;TNC;PTEN;MYL12B;PPP1CA;PAK1;COL4A1;COL6A1;RAPGEF1;PAK2;SOS2;MET
AMPK signaling pathway	9/120	0.14676860649208767	1.0	0	0	1.4999999999999998	2.8783470568576597	CCNA2;CRTC2;CPT1A;PFKFB3;PPP2R1A;AKT1S1;PPP2R3A;ELAVL1;FBP1
Measles	10/138	0.1534135194799526	1.0	0	0	1.4492753623188406	2.7168380604772677	STAT5A;HSPA8;MAVS;CCNE2;CHUK;OAS2;CYCS;RCHY1;TP53;IFNAR1
Signaling pathways regulating pluripotency of stem cells	10/139	0.15841964449431314	1.0	0	0	1.4388489208633093	2.651090343912608	FZD1;RIF1;FZD5;WNT7B;FZD9;AXIN1;DVL3;KLF4;LEFTY2;TBX3
Bacterial invasion of epithelial cells	6/74	0.1647057705275506	1.0	0	0	1.6216216216216217	2.924748009429989	ARHGEF26;CLTCL1;ELMO3;MET;SEPT2;SEPT3
PI3K-Akt signaling pathway	22/354	0.17338539253239038	1.0	0	0	1.2429378531073447	2.177923509151148	CRTC2;CHUK;LAMC3;ITGA3;PDGFB;TNC;PTEN;PPP2R3A;YWHAZ;NR4A1;CCNE2;PPP2R1A;COL4A1;DDIT4;KIT;COL6A1;MDM2;TP53;IL6R;SOS2;MET;IFNAR1
Proteasome	4/45	0.18643368284604128	1.0	0	0	1.7777777777777777	2.98609722860718	PSMB7;PSMB3;POMP;ADRM1
Mucin type O-glycan biosynthesis	3/31	0.20065196718317338	1.0	0	0	1.9354838709677418	3.1087420224475646	GALNT6;GALNT18;GCNT1
RNA transport	11/165	0.2040951724263157	1.0	0	0	1.3333333333333333	2.118891816571145	EIF4A1;XPO1;SMN2;SAP18;EIF3F;AAAS;EIF3D;RPP25L;SNUPN;EIF3A;EIF4G1
Nucleotide excision repair	4/47	0.20718336704116536	1.0	0	0	1.7021276595744679	2.679406036964871	CCNH;RFC2;RPA1;ERCC5
Proteoglycans in cancer	13/201	0.20737149638993704	1.0	0	0	1.2935323383084576	2.035041247122081	FZD1;FZD5;WNT7B;RDX;FZD9;RRAS2;PPP1CA;PAK1;MDM2;PDCD4;TP53;SOS2;MET
Primary bile acid biosynthesis	2/17	0.20773987788556972	1.0	0	0	2.352941176470588	3.6975731035436015	CYP46A1;SLC27A5
Prostate cancer	7/97	0.21155364258994297	1.0	0	0	1.4432989690721647	2.241842635816865	CCNE2;CHUK;PDGFB;MDM2;PTEN;TP53;SOS2
FoxO signaling pathway	9/132	0.21541314624406385	1.0	0	0	1.3636363636363635	2.0934511150206414	CDKN2B;HOMER1;GADD45B;CHUK;GADD45A;CCNG2;MDM2;PTEN;SOS2
Amino sugar and nucleotide sugar metabolism	4/48	0.21779787247025076	1.0	0	0	1.6666666666666665	2.540313061339135	CYB5R4;CYB5R3;UXS1;HEXA
Endocrine and other factor-regulated calcium reabsorption	4/48	0.21779787247025076	1.0	0	0	1.6666666666666665	2.540313061339135	ADCY9;CLTCL1;AP2S1;GNAS
Central carbon metabolism in cancer	5/65	0.2245509341987312	1.0	0	0	1.5384615384615385	2.2979272602185437	TIGAR;KIT;PTEN;TP53;MET
Phosphatidylinositol signaling system	7/99	0.2261619520902503	1.0	0	0	1.414141414141414	2.1021267756043183	MTMR3;CALML5;PPIP5K1;IPMK;PTEN;PIK3C2A;MTMR7
Non-small cell lung cancer	5/66	0.23381942521025603	1.0	0	0	1.5151515151515151	2.201827497975576	STAT5A;GADD45B;GADD45A;SOS2;TP53
Vibrio cholerae infection	4/50	0.2394412597417243	1.0	0	0	1.5999999999999999	2.287115446802478	ATP6V0B;ADCY9;KCNQ1;GNAS
Sphingolipid signaling pathway	8/119	0.24495576693425716	1.0	0	0	1.3445378151260503	1.8913312643532947	CERS6;PPP2R1A;SPHK1;PTEN;TRAF2;DEGS2;PPP2R3A;TP53
Ubiquitin mediated proteolysis	9/137	0.2472046870434335	1.0	0	0	1.313868613138686	1.8361820930540071	PIAS4;UBE2W;HERC2;UBA6;CUL2;MDM2;UBE2QL1;UBE2Z;RCHY1
Hepatitis C	10/155	0.24835258087462755	1.0	0	0	1.2903225806451613	1.7972978650277358	MAVS;CHUK;PPP2R1A;OAS2;CYCS;TRAF2;TP53;YWHAZ;SOS2;IFNAR1
Epithelial cell signaling in Helicobacter pylori infection	5/68	0.25266492029805	1.0	0	0	1.4705882352941175	2.023075137913094	ATP6V0B;PAK1;CHUK;ADAM10;MET
Colorectal cancer	6/86	0.25999953625691774	1.0	0	0	1.3953488372093021	1.8796401371099152	GADD45B;GADD45A;AXIN1;CYCS;SOS2;TP53
Phosphonate and phosphinate metabolism	1/6	0.26493667555327055	1.0	0	0	3.333333333333333	4.427548139092615	SELENOI
Regulation of actin cytoskeleton	13/214	0.27457791811646287	1.0	0	0	1.2149532710280373	1.5703516492420202	ITGA3;RDX;PDGFB;RRAS2;BRK1;F2;SSH2;MYL12B;PPP1CA;PAK1;PFN4;PAK2;SOS2
Insulin resistance	7/108	0.29558593657898286	1.0	0	0	1.296296296296296	1.5799203089302307	PTPN1;SLC27A1;CRTC2;CPT1A;PTEN;SLC27A5;PPP1CA
Hepatitis B	10/163	0.2988597106982444	1.0	0	0	1.2269938650306749	1.4819398904135106	STAT5A;CCNA2;MAVS;CCNE2;CHUK;CYCS;TP53;YWHAZ;SOS2;IFNAR1
Other types of O-glycan biosynthesis	2/22	0.30185830293267685	1.0	0	0	1.8181818181818181	2.1778137587293127	B4GALT2;GXYLT2
Osteoclast differentiation	8/127	0.3026458393583639	1.0	0	0	1.2598425196850394	1.5057537059644543	JUND;TEC;CHUK;IFNGR2;ACP5;TREM2;TRAF2;IFNAR1
Viral carcinogenesis	12/201	0.3054856995308486	1.0	0	0	1.1940298507462686	1.4159430585223085	STAT5A;CCNA2;CDKN2B;TBP;CCNE2;SRF;MDM2;HIST1H4I;TRAF2;TP53;YWHAZ;GTF2E2
Inositol phosphate metabolism	5/74	0.31110059336369467	1.0	0	0	1.3513513513513513	1.577890496988918	MTMR3;IPMK;PTEN;PIK3C2A;MTMR7
Protein processing in endoplasmic reticulum	10/165	0.3118918000294854	1.0	0	0	1.2121212121212122	1.4122411467844365	HSPA8;NSFL1C;SEC24B;RPN2;PRKCSH;SEL1L;TRAF2;RRBP1;SEL1L2;DDOST
Purine metabolism	8/129	0.3175386800933424	1.0	0	0	1.2403100775193798	1.422828702020539	NUDT9;GUCY1A2;NT5E;ADCY9;ATIC;PKLR;PDE8A;ITPA
Mannose type O-glycan biosynthesis	2/23	0.32060036735466374	1.0	0	0	1.7391304347826086	1.9783650312564471	B4GALT2;B4GAT1
Mismatch repair	2/23	0.32060036735466374	1.0	0	0	1.7391304347826086	1.9783650312564471	RFC2;RPA1
Gastric acid secretion	5/75	0.32103520904984706	1.0	0	0	1.3333333333333333	1.5149393018047932	SLC9A4;ADCY9;CALML5;KCNQ1;GNAS
Pancreatic cancer	5/75	0.32103520904984706	1.0	0	0	1.3333333333333333	1.5149393018047932	RALBP1;CHUK;GADD45B;GADD45A;TP53
Phospholipase D signaling pathway	9/148	0.32185346752169186	1.0	0	0	1.2162162162162162	1.3787743461346562	CYTH3;ADCY9;SPHK1;KIT;PDGFB;GNAS;RRAS2;F2;SOS2
Ferroptosis	3/40	0.3232493972692518	1.0	0	0	1.4999999999999998	1.693996688892286	MAP1LC3A;ACSL1;TP53
Transcriptional misregulation in cancer	11/186	0.3274334996806609	1.0	0	0	1.1827956989247312	1.3205562675579576	ARNT2;CDKN2C;GADD45B;GADD45A;PRCC;MDM2;HIST1H3H;TP53;ETV4;MET;AFF1
Riboflavin metabolism	1/8	0.33662794865636386	1.0	0	0	2.5	2.721942421048515	ACP5
Homologous recombination	3/41	0.3371468638537048	1.0	0	0	1.4634146341463412	1.5910780182096236	RAD51B;RPA1;PALB2
Viral myocarditis	4/59	0.3411916398273588	1.0	0	0	1.3559322033898304	1.458048767361736	CXADR;CYCS;HLA-DOA;EIF4G1
Hematopoietic cell lineage	6/97	0.3569285827398046	1.0	0	0	1.2371134020618557	1.2744984316239885	ITGA3;KIT;CD1E;CD1D;HLA-DOA;IL6R
Fatty acid degradation	3/44	0.3786697727707907	1.0	0	0	1.3636363636363635	1.3242146804495836	CPT1A;ACSL1;ACADM
Neurotrophin signaling pathway	7/119	0.3853715393039042	1.0	0	0	1.176470588235294	1.1218204386945247	CALML5;ARHGDIG;RAPGEF1;TP53;SOS2;SH2B3;MAP2K5
ECM-receptor interaction	5/82	0.39117601725719064	1.0	0	0	1.2195121951219512	1.1446312783908745	LAMC3;ITGA3;COL4A1;COL6A1;TNC
Glycosphingolipid biosynthesis	3/45	0.3924009183942127	1.0	0	0	1.3333333333333333	1.2472949477860094	B4GALT2;HEXA;B3GALT5
Ribosome biogenesis in eukaryotes	6/101	0.39300017337866283	1.0	0	0	1.188118811881188	1.109637892212941	LSG1;UTP6;XPO1;NOB1;NHP2;RPP25L
T cell receptor signaling pathway	6/101	0.39300017337866283	1.0	0	0	1.188118811881188	1.109637892212941	PAK1;TEC;CHUK;SOS2;PAK2;NCK1
Wnt signaling pathway	9/158	0.3930161491766438	1.0	0	0	1.1392405063291138	1.0639419219166353	FZD1;ZNRF3;FZD5;WNT7B;FZD9;AXIN1;DVL3;PRICKLE1;TP53
Cortisol synthesis and secretion	4/65	0.41006047139933866	1.0	0	0	1.2307692307692308	1.0971700171589474	NR4A1;ADCY9;GNAS;PDE8A
Glucagon signaling pathway	6/103	0.41102972546232486	1.0	0	0	1.1650485436893203	1.035832709563524	CRTC2;CPT1A;CALML5;GNAS;PPP4R3A;FBP1
Lysosome	7/123	0.4184152232009605	1.0	0	0	1.1382113821138211	0.9917019313802579	ATP6V0B;GM2A;CLTCL1;HEXA;ACP5;CTSV;LIPA
Axon guidance	10/181	0.41931924164335166	1.0	0	0	1.1049723756906076	0.9603566142967724	NRP1;PAK1;CDK5;UNC5B;TRPC4;SSH2;MET;PAK2;MYL12B;NCK1
Hedgehog signaling pathway	3/47	0.4196120451603213	1.0	0	0	1.276595744680851	1.1086272722292005	SUFU;PTCH2;CSNK1D
Sphingolipid metabolism	3/47	0.4196120451603213	1.0	0	0	1.276595744680851	1.1086272722292005	CERS6;SPHK1;DEGS2
ErbB signaling pathway	5/85	0.42118396120911705	1.0	0	0	1.176470588235294	1.0172771508801166	STAT5A;PAK1;SOS2;PAK2;NCK1
Acute myeloid leukemia	4/66	0.421430857889875	1.0	0	0	1.2121212121212122	1.0473933978386722	STAT5A;CHUK;KIT;SOS2
Apoptosis	8/143	0.42422531374724404	1.0	0	0	1.1188811188811187	0.959430002289309	PARP4;GADD45B;CHUK;GADD45A;CYCS;TRAF2;CTSV;TP53
MicroRNAs in cancer	16/299	0.4265501427827626	1.0	0	0	1.0702341137123745	0.9118665962690133	RDX;PDGFB;TNC;PTEN;MIRLET7I;MIR135B;MIRLET7E;CCNE2;DDIT4;MDM2;PDCD4;MIR150;MIR192;TP53;SOS2;MET
Platelet activation	7/124	0.42665940706055616	1.0	0	0	1.129032258064516	0.9616749321100159	GUCY1A2;ADCY9;P2RX1;GNAS;F2;MYL12B;PPP1CA
Insulin secretion	5/86	0.4311336138274714	1.0	0	0	1.1627906976744184	0.9782991023729873	RAB3A;ADCY9;KCNMB3;GNAS;KCNN2
Taurine and hypotaurine metabolism	1/11	0.43128166280518815	1.0	0	0	1.8181818181818181	1.529079804244035	GGT6
Adrenergic signaling in cardiomyocytes	8/145	0.4395232982954594	1.0	0	0	1.103448275862069	0.9071057129387737	ADCY9;CALML5;PPP2R1A;KCNQ1;CREM;GNAS;PPP2R3A;PPP1CA
Arginine and proline metabolism	3/49	0.44640402063272916	1.0	0	0	1.2244897959183672	0.987588809585937	PYCR1;SRM;AGMAT
Glyoxylate and dicarboxylate metabolism	2/30	0.44657352514826887	1.0	0	0	1.3333333333333333	1.0748682963163632	GCSH;DLD
Pentose phosphate pathway	2/30	0.44657352514826887	1.0	0	0	1.3333333333333333	1.0748682963163632	IDNK;FBP1
Adipocytokine signaling pathway	4/69	0.45518892642326336	1.0	0	0	1.1594202898550725	0.9125133023815558	CPT1A;CHUK;ACSL1;TRAF2
Autophagy	7/128	0.45946687100202477	1.0	0	0	1.09375	0.8505967287493645	SH3GLB1;IGBP1;MTMR3;DDIT4;AKT1S1;PTEN;RRAS2
N-Glycan biosynthesis	3/50	0.4596144044474325	1.0	0	0	1.2	0.9328408706750739	B4GALT2;RPN2;DDOST
Circadian rhythm	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	BHLHE41;CSNK1D
Galactose metabolism	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	B4GALT2;AKR1B10
beta-Alanine metabolism	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	ACADM;SRM
Protein digestion and absorption	5/90	0.4705185605943169	1.0	0	0	1.111111111111111	0.8376887467502594	DPP4;COL5A1;COL4A1;KCNQ1;COL6A1
TGF-beta signaling pathway	5/90	0.4705185605943169	1.0	0	0	1.111111111111111	0.8376887467502594	LEFTY1;CDKN2B;PPP2R1A;AMH;LEFTY2
Amyotrophic lateral sclerosis (ALS)	3/51	0.47268752481329424	1.0	0	0	1.176470588235294	0.881553803378603	ALS2;CYCS;TP53
Propanoate metabolism	2/32	0.4801831856912929	1.0	0	0	1.25	0.9169845137852034	ACADM;DLD
mRNA surveillance pathway	5/91	0.48023571472567267	1.0	0	0	1.0989010989010988	0.8060200255732013	PPP2R1A;SAP18;PPP2R3A;GSPT1;PPP1CA
Dopaminergic synapse	7/131	0.4838055078602633	1.0	0	0	1.0687022900763359	0.7759551258061761	CALML5;CALY;PPP2R1A;KIF5B;GNAS;PPP2R3A;PPP1CA
Fatty acid biosynthesis	1/13	0.48676267554205266	1.0	0	0	1.5384615384615385	1.107659375220991	ACSL1
Non-homologous end-joining	1/13	0.48676267554205266	1.0	0	0	1.5384615384615385	1.107659375220991	POLM
Bile secretion	4/72	0.48826565745953704	1.0	0	0	1.111111111111111	0.7965507124555724	ADCY9;GNAS;KCNN2;SLC27A5
Th1 and Th2 cell differentiation	5/92	0.48989166823392183	1.0	0	0	1.0869565217391304	0.7756206495188073	STAT5A;CHUK;MAML1;IFNGR2;HLA-DOA
Base excision repair	2/33	0.496510840077104	1.0	0	0	1.2121212121212122	0.8486666215153239	PARP4;MPG
IL-17 signaling pathway	5/93	0.4994819883860412	1.0	0	0	1.075268817204301	0.7464341299256831	JUND;CHUK;TRAF2;ELAVL1;IL17RC
Toxoplasmosis	6/113	0.4997075653239782	1.0	0	0	1.0619469026548671	0.7367067833785346	HSPA8;CHUK;LAMC3;IFNGR2;CYCS;HLA-DOA
Pentose and glucuronate interconversions	2/34	0.5125071338352726	1.0	0	0	1.176470588235294	0.7864007628092599	AKR1B10;XYLB
SNARE interactions in vesicular transport	2/34	0.5125071338352726	1.0	0	0	1.176470588235294	0.7864007628092599	GOSR2;STX2
Legionellosis	3/55	0.5234350892650081	1.0	0	0	1.0909090909090908	0.706191545588209	EEF1G;HSPA8;CYCS
Pathogenic Escherichia coli infection	3/55	0.5234350892650081	1.0	0	0	1.0909090909090908	0.706191545588209	TUBB1;YWHAZ;NCK1
Estrogen signaling pathway	7/137	0.5314567341654012	1.0	0	0	1.021897810218978	0.645975826925556	HSPA8;ADCY9;CALML5;GNAS;KRT20;SOS2;EBAG9
Insulin signaling pathway	7/137	0.5314567341654012	1.0	0	0	1.021897810218978	0.645975826925556	PTPN1;CALML5;PKLR;RAPGEF1;SOS2;FBP1;PPP1CA
Glutathione metabolism	3/56	0.5356989644779965	1.0	0	0	1.0714285714285714	0.6687674026318335	GGT6;CHAC2;SRM
Circadian entrainment	5/97	0.5371052771771576	1.0	0	0	1.0309278350515463	0.6407846977351693	GUCY1A2;MTNR1A;ADCY9;CALML5;GNAS
DNA replication	2/36	0.5434764066615513	1.0	0	0	1.111111111111111	0.6775210926327332	RFC2;RPA1
Pyrimidine metabolism	3/57	0.5477812798713707	1.0	0	0	1.0526315789473684	0.6335570484502631	NT5E;UPRT;UCKL1
Inflammatory mediator regulation of TRP channels	5/100	0.5644459548061124	1.0	0	0	1.0	0.5719106399118082	ADCY9;CALML5;GNAS;TRPV3;PPP1CA
Lysine degradation	3/59	0.5713815260202666	1.0	0	0	1.0169491525423728	0.5691845296161483	KMT5C;DLD;AASS
Herpes simplex virus 1 infection	24/492	0.5799272456848159	1.0	0	0	0.975609756097561	0.531563533447991	ZNF154;ZNF583;ZNF285;CHUK;IFNGR2;ZNF181;TRAF2;ZNF23;PPP1CA;MAVS;ZNF707;ZNF607;OAS2;ZNF713;CYCS;ZNF557;ZNF324;HLA-DOA;ZNF841;ZNF224;TP53;ZNF641;ZNF398;IFNAR1
Nitrogen metabolism	1/17	0.5820286217003197	1.0	0	0	1.176470588235294	0.6367478285654856	CA4
Long-term depression	3/60	0.5828910435264506	1.0	0	0	1.0	0.5397549994176116	GUCY1A2;PPP2R1A;GNAS
Pyruvate metabolism	2/39	0.5873014514915549	1.0	0	0	1.0256410256410255	0.5458636358886607	PKLR;DLD
Oocyte meiosis	6/125	0.5991206229248341	1.0	0	0	0.96	0.4918006342162246	ADCY9;CALML5;CCNE2;PPP2R1A;YWHAZ;PPP1CA
C-type lectin receptor signaling pathway	5/104	0.599573857726415	1.0	0	0	0.9615384615384616	0.49186164733317733	PAK1;CALML5;CHUK;MDM2;RRAS2
Glycine, serine and threonine metabolism	2/40	0.60119891797304	1.0	0	0	1.0	0.5088294208836465	GCSH;DLD
Peroxisome	4/83	0.6012622374752512	1.0	0	0	0.963855421686747	0.4903364861494962	ACSL1;AGPS;PEX11B;PAOX
Other glycan degradation	1/18	0.6029449082085762	1.0	0	0	1.111111111111111	0.5621438325188578	HEXA
Thermogenesis	11/231	0.6093800775213675	1.0	0	0	0.9523809523809523	0.4717267665923641	SMARCE1;CPT1A;ADCY9;NDUFB6;ACSL1;NDUFAB1;AKT1S1;GNAS;ARID1A;SOS2;COX20
Bladder cancer	2/41	0.6147400385913487	1.0	0	0	0.975609756097561	0.47468858733322344	MDM2;TP53
Ras signaling pathway	11/232	0.6151143798879258	1.0	0	0	0.9482758620689654	0.46081185293266835	PAK1;RALBP1;HTR7;CALML5;CHUK;KIT;PDGFB;RRAS2;PAK2;SOS2;MET
Glycosaminoglycan degradation	1/19	0.6228154838888618	1.0	0	0	1.0526315789473684	0.4984262922061619	HEXA
Pantothenate and CoA biosynthesis	1/19	0.6228154838888618	1.0	0	0	1.0526315789473684	0.4984262922061619	COASY
Th17 cell differentiation	5/107	0.6248402405451496	1.0	0	0	0.9345794392523363	0.43949465144730016	STAT5A;CHUK;IFNGR2;HLA-DOA;IL6R
Alzheimer disease	8/171	0.6268081564909365	1.0	0	0	0.935672514619883	0.4370664380599916	CALML5;CDK5;LRP1;NDUFB6;NDUFAB1;ADAM10;CYCS;IDE
Influenza A	8/171	0.6268081564909365	1.0	0	0	0.935672514619883	0.4370664380599916	HSPA8;MAVS;XPO1;OAS2;IFNGR2;CYCS;HLA-DOA;IFNAR1
Huntington disease	9/193	0.6324859877108375	1.0	0	0	0.9326424870466321	0.4272409235217067	TBP;NDUFB6;POLR2B;DCTN4;NDUFAB1;CLTCL1;AP2S1;CYCS;TP53
Inflammatory bowel disease (IBD)	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	IFNGR2;HLA-DOA;IL18R1
Mitophagy	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	CITED2;RRAS2;TP53
Shigellosis	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	CHUK;PFN4;ELMO3
Vascular smooth muscle contraction	6/132	0.6519118466202043	1.0	0	0	0.9090909090909091	0.3889508461515316	GUCY1A2;ADCY9;CALML5;KCNMB3;GNAS;PPP1CA
Systemic lupus erythematosus	6/133	0.6590954237799057	1.0	0	0	0.9022556390977443	0.3761386051870259	H2AFY2;C1R;HIST1H3H;HIST1H4I;HLA-DOA;SNRPB
Salivary secretion	4/90	0.6647641861492688	1.0	0	0	0.8888888888888888	0.362953696452133	GUCY1A2;ADCY9;CALML5;GNAS
Spliceosome	6/134	0.6661861556783615	1.0	0	0	0.8955223880597014	0.36374877713522197	HSPA8;PRPF40B;RP9;CWC15;SNRPC;SNRPB
Amphetamine addiction	3/68	0.6676380497864279	1.0	0	0	0.8823529411764706	0.3564786122927678	CALML5;GNAS;PPP1CA
Glycolysis / Gluconeogenesis	3/68	0.6676380497864279	1.0	0	0	0.8823529411764706	0.3564786122927678	PKLR;FBP1;DLD
Serotonergic synapse	5/113	0.6723926318192525	1.0	0	0	0.8849557522123893	0.3512502969378424	HTR7;KCND2;GNAS;KCNN2;SLC6A4
Dilated cardiomyopathy (DCM)	4/91	0.6732482464251353	1.0	0	0	0.8791208791208791	0.34781639730574376	ADCY9;ITGA3;GNAS;EMD
Renin secretion	3/69	0.6772948191670352	1.0	0	0	0.8695652173913043	0.338824888725687	GUCY1A2;CALML5;GNAS
Endocytosis	11/244	0.6804800816371734	1.0	0	0	0.9016393442622951	0.3470921313586251	SH3GLB1;CYTH3;HSPA8;DAB2;CAPZB;KIF5B;CLTCL1;AP2S1;MDM2;WASHC2A;RNF41
RIG-I-like receptor signaling pathway	3/70	0.6867423738774998	1.0	0	0	0.8571428571428571	0.32211090747805676	MAVS;CHUK;TRAF2
Cysteine and methionine metabolism	2/47	0.6886033156551076	1.0	0	0	0.8510638297872339	0.3175233302317852	MTAP;SRM
Ether lipid metabolism	2/47	0.6886033156551076	1.0	0	0	0.8510638297872339	0.3175233302317852	AGPS;SELENOI
GnRH signaling pathway	4/93	0.6897669196744971	1.0	0	0	0.8602150537634409	0.3194851922842808	ADCY9;CALML5;GNAS;SOS2
Proximal tubule bicarbonate reclamation	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	CA4
Renin-angiotensin system	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	PREP
Human cytomegalovirus infection	10/225	0.6932935578880997	1.0	0	0	0.8888888888888888	0.32560156891656883	ADCY9;CALML5;CHUK;GNAS;MDM2;CYCS;TRAF2;TP53;IL6R;SOS2
Notch signaling pathway	2/48	0.6997136081858564	1.0	0	0	0.8333333333333333	0.29757013234898655	MAML1;DVL3
Valine, leucine and isoleucine degradation	2/48	0.6997136081858564	1.0	0	0	0.8333333333333333	0.29757013234898655	ACADM;DLD
Fluid shear stress and atherosclerosis	6/139	0.7002204199629493	1.0	0	0	0.8633093525179856	0.30764901396557814	PIAS4;CALML5;CHUK;PDGFB;TP53;MAP2K5
NF-kappa B signaling pathway	4/95	0.7056844804748206	1.0	0	0	0.8421052631578947	0.2935469919093557	PIAS4;CHUK;GADD45B;TRAF2
JAK-STAT signaling pathway	7/162	0.7061186960436059	1.0	0	0	0.8641975308641975	0.300716483504727	PIAS4;STAT5A;IFNGR2;PDGFB;IL6R;SOS2;IFNAR1
Vitamin digestion and absorption	1/24	0.7082222339049663	1.0	0	0	0.8333333333333333	0.28749778737100123	SLC52A3
Cocaine addiction	2/49	0.7104927276749392	1.0	0	0	0.8163265306122448	0.2790176057147895	CDK5;GNAS
Malaria	2/49	0.7104927276749392	1.0	0	0	0.8163265306122448	0.2790176057147895	LRP1;MET
Ovarian steroidogenesis	2/49	0.7104927276749392	1.0	0	0	0.8163265306122448	0.2790176057147895	ADCY9;GNAS
Amoebiasis	4/96	0.7134178055156833	1.0	0	0	0.8333333333333333	0.28140670641508325	LAMC3;COL4A1;GNAS;CD1D
Glycerophospholipid metabolism	4/97	0.7210011321847114	1.0	0	0	0.8247422680412371	0.269785213526288	GPD2;PNPLA6;CRLS1;SELENOI
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/25	0.7228285803914951	1.0	0	0	0.7999999999999999	0.2596665438632063	GPAA1
Aldosterone synthesis and secretion	4/98	0.7284348779278988	1.0	0	0	0.8163265306122448	0.25865881578997496	NR4A1;ADCY9;CALML5;GNAS
Mineral absorption	2/51	0.7310789651903944	1.0	0	0	0.7843137254901961	0.24567356984329963	TRPM6;MT1E
Folate biosynthesis	1/26	0.7367044256304639	1.0	0	0	0.7692307692307693	0.2350527061077511	AKR1B10
Maturity onset diabetes of the young	1/26	0.7367044256304639	1.0	0	0	0.7692307692307693	0.2350527061077511	PKLR
HIF-1 signaling pathway	4/100	0.7428559954663433	1.0	0	0	0.7999999999999999	0.23780245442692988	PFKFB3;IFNGR2;CUL2;IL6R
Biosynthesis of unsaturated fatty acids	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	TECR
Collecting duct acid secretion	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	SLC12A7
Fatty acid elongation	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	TECR
Glycosaminoglycan biosynthesis	2/53	0.7504077852742062	1.0	0	0	0.7547169811320754	0.21670830680118947	B4GALT2;CHSY1
Tight junction	7/170	0.7517812588214371	1.0	0	0	0.8235294117647058	0.23496107482455797	PATJ;PPP2R1A;RDX;CD1E;CD1D;CGNL1;MYL12B
Longevity regulating pathway	4/102	0.7566871822236416	1.0	0	0	0.7843137254901961	0.21867085840898748	HSPA8;ADCY9;AKT1S1;TP53
Non-alcoholic fatty liver disease (NAFLD)	6/149	0.7610356577983485	1.0	0	0	0.8053691275167785	0.21992622742208362	NDUFB6;PKLR;NDUFAB1;CYCS;TRAF2;IL6R
Phototransduction	1/28	0.7624087879510514	1.0	0	0	0.7142857142857142	0.19376600001083732	CALML5
RNA degradation	3/79	0.7625315297227274	1.0	0	0	0.7594936708860759	0.2059074082780564	HSPA9;CNOT6L;EXOSC3
Chagas disease (American trypanosomiasis)	4/103	0.7633839575456066	1.0	0	0	0.7766990291262135	0.20970419679401037	CHUK;PPP2R1A;IFNGR2;GNAS
Regulation of lipolysis in adipocytes	2/55	0.7685284162153218	1.0	0	0	0.7272727272727272	0.1914747203489268	ADCY9;GNAS
Parathyroid hormone synthesis, secretion and action	4/106	0.7826130830889017	1.0	0	0	0.7547169811320754	0.1849938504751301	ADCY9;JUND;MMP15;GNAS
Oxytocin signaling pathway	6/153	0.7826524992964198	1.0	0	0	0.7843137254901961	0.19220901041264157	GUCY1A2;ADCY9;CALML5;GNAS;MAP2K5;PPP1CA
Citrate cycle (TCA cycle)	1/30	0.785605993701368	1.0	0	0	0.6666666666666666	0.16086659500936684	DLD
Nicotinate and nicotinamide metabolism	1/30	0.785605993701368	1.0	0	0	0.6666666666666666	0.16086659500936684	NT5E
Asthma	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	HLA-DOA
RNA polymerase	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	POLR2B
Tuberculosis	7/179	0.7968264892762255	1.0	0	0	0.7821229050279329	0.17763444702070694	HSPA9;ATP6V0B;CALML5;SPHK1;IFNGR2;CYCS;HLA-DOA
VEGF signaling pathway	2/59	0.8013529002820844	1.0	0	0	0.6779661016949152	0.15013820630777816	MAPKAPK3;SPHK1
Alcoholism	7/180	0.8014249468669339	1.0	0	0	0.7777777777777778	0.17217196278867253	CALML5;H2AFY2;GNAS;HIST1H3H;HIST1H4I;SOS2;PPP1CA
Salmonella infection	3/86	0.8106028254070419	1.0	0	0	0.6976744186046511	0.14649563666446674	IFNGR2;PFN4;KLC1
Rap1 signaling pathway	8/206	0.8139007806443227	1.0	0	0	0.7766990291262135	0.15993538758000875	ADCY9;CALML5;KIT;PDGFB;RAPGEF1;GNAS;PFN4;MET
Necroptosis	6/162	0.8258200247560288	1.0	0	0	0.7407407407407407	0.14176179030125863	STAT5A;PARP4;H2AFY2;IFNGR2;TRAF2;IFNAR1
Kaposi sarcoma-associated herpesvirus infection	7/186	0.8273600898825334	1.0	0	0	0.7526881720430108	0.1426458959005734	CALML5;CHUK;PDGFB;CYCS;TRAF2;TP53;IFNAR1
Cytosolic DNA-sensing pathway	2/63	0.8299778549215587	1.0	0	0	0.6349206349206349	0.1183214345173536	MAVS;CHUK
Morphine addiction	3/91	0.8396768561291149	1.0	0	0	0.6593406593406593	0.11521197114942941	ADCY9;GNAS;PDE8A
Rheumatoid arthritis	3/91	0.8396768561291149	1.0	0	0	0.6593406593406593	0.11521197114942941	ATP6V0B;ACP5;HLA-DOA
cGMP-PKG signaling pathway	6/166	0.8426824754400535	1.0	0	0	0.7228915662650601	0.1237337726371208	GUCY1A2;ADCY9;CALML5;SRF;KCNMB3;PPP1CA
African trypanosomiasis	1/37	0.8503713249208762	1.0	0	0	0.5405405405405406	0.08761198488762709	HPR
Long-term potentiation	2/67	0.8548301611907013	1.0	0	0	0.5970149253731343	0.0936432666623936	CALML5;PPP1CA
Allograft rejection	1/38	0.8578665401729517	1.0	0	0	0.5263157894736842	0.08068775746154062	HLA-DOA
Staphylococcus aureus infection	2/68	0.860502636162266	1.0	0	0	0.588235294117647	0.08837564694787858	C1R;HLA-DOA
Prolactin signaling pathway	2/70	0.8712429450339811	1.0	0	0	0.5714285714285714	0.0787625225498065	STAT5A;SOS2
Nicotine addiction	1/40	0.8717504251826977	1.0	0	0	0.5	0.06862605284591321	CHRNA6
Pancreatic secretion	3/98	0.8738518002871013	1.0	0	0	0.6122448979591836	0.08255784648566498	ADCY9;KCNQ1;GNAS
B cell receptor signaling pathway	2/71	0.8763229800185758	1.0	0	0	0.5633802816901409	0.07437777878706983	CHUK;SOS2
Graft-versus-host disease	1/41	0.878175666331951	1.0	0	0	0.4878048780487805	0.0633700633222169	HLA-DOA
Adherens junction	2/72	0.8812175551168138	1.0	0	0	0.5555555555555555	0.07025041245674381	PTPN1;MET
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	2/72	0.8812175551168138	1.0	0	0	0.5555555555555555	0.07025041245674381	ITGA3;EMD
Tryptophan metabolism	1/42	0.8842793063304941	1.0	0	0	0.47619047619047616	0.05856300421956226	DLD
NOD-like receptor signaling pathway	6/178	0.8854491489065579	1.0	0	0	0.6741573033707865	0.08201814595048382	MAVS;CHUK;IFI16;OAS2;TRAF2;IFNAR1
Ribosome	5/153	0.8857037800624997	1.0	0	0	0.6535947712418301	0.07932857404860826	RPL36A-HNRNPH2;RPL14;RPL26;RPL10A;RPS11
Type I diabetes mellitus	1/43	0.8900774268754144	1.0	0	0	0.46511627906976744	0.05416131327939396	HLA-DOA
Leishmaniasis	2/74	0.8904734986911036	1.0	0	0	0.5405405405405406	0.06270374958254536	IFNGR2;HLA-DOA
Thyroid hormone synthesis	2/74	0.8904734986911036	1.0	0	0	0.5405405405405406	0.06270374958254536	ADCY9;GNAS
Relaxin signaling pathway	4/130	0.8949983560248933	1.0	0	0	0.6153846153846154	0.06826670618625434	ADCY9;COL4A1;GNAS;SOS2
Carbohydrate digestion and absorption	1/44	0.8955853061573006	1.0	0	0	0.45454545454545453	0.05012627322480098	SLC2A5
Natural killer cell mediated cytotoxicity	4/131	0.8983079302400212	1.0	0	0	0.6106870229007633	0.06549151922621713	PAK1;IFNGR2;SOS2;IFNAR1
Pertussis	2/76	0.8990559259149057	1.0	0	0	0.5263157894736842	0.056005282852014004	CALML5;C1R
ABC transporters	1/45	0.9008174591944802	1.0	0	0	0.4444444444444444	0.046423395514619575	ABCA5
Antigen processing and presentation	2/77	0.9031081450221422	1.0	0	0	0.5194805194805194	0.05294180301649679	HSPA8;HLA-DOA
Type II diabetes mellitus	1/46	0.9057876758651223	1.0	0	0	0.43478260869565216	0.04302189293649987	PKLR
cAMP signaling pathway	7/212	0.9102489016760925	1.0	0	0	0.660377358490566	0.06210003677512062	PAK1;ADCY9;CALML5;GNAS;RRAS2;AMH;PPP1CA
Complement and coagulation cascades	2/79	0.9107606472852537	1.0	0	0	0.5063291139240506	0.047329191130890166	C1R;F2
Calcium signaling pathway	6/188	0.9131597476168598	1.0	0	0	0.6382978723404255	0.0579858151181627	HTR7;ADCY9;CALML5;SPHK1;P2RX1;GNAS
Intestinal immune network for IgA production	1/48	0.914994048233663	1.0	0	0	0.41666666666666663	0.03701571599601437	HLA-DOA
Apelin signaling pathway	4/137	0.9162983017532836	1.0	0	0	0.583941605839416	0.05104426883901789	ADCY9;CALML5;SPHK1;RRAS2
TNF signaling pathway	3/110	0.9176399007049346	1.0	0	0	0.5454545454545454	0.04688194382454664	CHUK;TRAF2;IL18R1
Cholinergic synapse	3/112	0.9234195962447295	1.0	0	0	0.5357142857142857	0.04268118605193645	ADCY9;KCNQ1;CHRNA6
Glutamatergic synapse	3/114	0.9288257077278166	1.0	0	0	0.5263157894736842	0.038860089762793495	ADCY9;HOMER1;GNAS
Parkinson disease	4/142	0.9290588553855328	1.0	0	0	0.5633802816901409	0.04145531757308912	NDUFB6;LRRK2;NDUFAB1;CYCS
Hypertrophic cardiomyopathy (HCM)	2/85	0.9304527474425885	1.0	0	0	0.47058823529411764	0.03392187580644571	ITGA3;EMD
Thyroid hormone signaling pathway	3/116	0.9338791037872658	1.0	0	0	0.5172413793103448	0.035383597412689746	THRB;MDM2;TP53
Autoimmune thyroid disease	1/53	0.9342669389173686	1.0	0	0	0.3773584905660377	0.02565776594269266	HLA-DOA
Fc gamma R-mediated phagocytosis	2/91	0.9459848142593618	1.0	0	0	0.43956043956043955	0.024408247313871943	PAK1;SPHK1
Phagosome	4/152	0.9494463614039064	1.0	0	0	0.5263157894736842	0.02730328512521963	ATP6V0B;C1R;TUBB1;HLA-DOA
Glycerolipid metabolism	1/61	0.956442628953957	1.0	0	0	0.32786885245901637	0.014601466257298934	AKR1B10
Human immunodeficiency virus 1 infection	6/212	0.9571350180193815	1.0	0	0	0.5660377358490566	0.024798573294869786	PAK1;CALML5;CHUK;CYCS;TRAF2;PAK2
Choline metabolism in cancer	2/99	0.9616193258375976	1.0	0	0	0.40404040404040403	0.015812774876077424	PDGFB;SOS2
Progesterone-mediated oocyte maturation	2/99	0.9616193258375976	1.0	0	0	0.40404040404040403	0.015812774876077424	CCNA2;ADCY9
AGE-RAGE signaling pathway in diabetic complications	2/100	0.9632369873558141	1.0	0	0	0.39999999999999997	0.014982321868347009	STAT5A;COL4A1
Oxidative phosphorylation	3/133	0.9652081031256262	1.0	0	0	0.45112781954887216	0.015975135331615462	ATP6V0B;NDUFB6;NDUFAB1
Aminoacyl-tRNA biosynthesis	1/66	0.9663236546235302	1.0	0	0	0.30303030303030304	0.010380743845736572	MTFMT
Retinol metabolism	1/67	0.9680129340715097	1.0	0	0	0.29850746268656714	0.00970442691065804	RDH8
Toll-like receptor signaling pathway	2/104	0.9690762134019278	1.0	0	0	0.38461538461538464	0.0120815456087189	CHUK;IFNAR1
Fc epsilon RI signaling pathway	1/68	0.9696175495526317	1.0	0	0	0.2941176470588235	0.009074577660222398	SOS2
Drug metabolism	2/108	0.9740164985643297	1.0	0	0	0.37037037037037035	0.009750754261227252	ITPA;UCKL1
Retrograde endocannabinoid signaling	3/148	0.9806622539772427	1.0	0	0	0.40540540540540543	0.007916418722549444	ADCY9;NDUFB6;NDUFAB1
Chemokine signaling pathway	4/190	0.9871407452940422	1.0	0	0	0.42105263157894735	0.005449537108559381	PAK1;ADCY9;CHUK;SOS2
GABAergic synapse	1/89	0.9896959732105118	1.0	0	0	0.2247191011235955	0.002327523771873428	ADCY9
Cytokine-cytokine receptor interaction	7/294	0.9923269252224658	1.0	0	0	0.47619047619047616	0.003667935368858527	IFNGR2;TNFSF9;AMH;IL17RC;IL6R;IL18R1;IFNAR1
Cell adhesion molecules (CAMs)	2/145	0.9950204333502967	1.0	0	0	0.27586206896551724	0.0013771051045397963	SDC3;HLA-DOA
Neuroactive ligand-receptor interaction	8/338	0.9953295857706447	1.0	0	0	0.47337278106508873	0.0022160258894721677	MTNR1A;HTR7;MC1R;THRB;P2RX1;CHRNA6;CHRNA10;F2
Leukocyte transendothelial migration	1/112	0.9968503216903181	1.0	0	0	0.17857142857142855	5.633301761622566E-4	MYL12B
Olfactory transduction	4/444	0.9999954183025136	1.0	0	0	0.18018018018018017	8.255329698042262E-7	OR7A10;CALML5;OR2M3;OR10A3
